The psychological consequences of androgenetic alopecia: A systematic review.

androgenetic alopecia hair disorders psychocutaneous disorders psychodermatology psychotrichology

Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
Jan 2023
Historique:
revised: 18 02 2022
received: 28 12 2021
accepted: 08 04 2022
pubmed: 12 4 2022
medline: 24 1 2023
entrez: 11 4 2022
Statut: ppublish

Résumé

Androgenetic alopecia is the most common cause of hair loss in both males and females. In a society that places significant value on hair and associates it with attractiveness, a lack there of can have damaging psychological consequences. The psychosocial impact of hair loss is often overlooked due to the medically benign nature of offending conditions. Addressing the psychological aspects of androgenetic alopecia can improve holistic patient care and patient outcomes. A search was conducted in PubMed using the following search strategy: androgenetic alopecia AND anxiety OR depression OR psychological OR psychosocial OR self-esteem. Studies were excluded if they focused on any other type of alopecia or were published in a language other than English. A total of 13 studies were retained after the initial search process. The included studies date from 1992 to 2021. They all conclude that androgenetic alopecia serves as a significant psychosocial stressor in the lives of those affected. It impairs quality of life according to multiple measures. The data examined from these studies shed light on the increased need to attend to the psychosocial comorbidity associated with androgenetic alopecia. These hair-loss patients often present to dermatology clinics to seek treatment but would also benefit from psychological support.

Identifiants

pubmed: 35403805
doi: 10.1111/jocd.14983
pmc: PMC10084176
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-95

Informations de copyright

© 2022 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.

Références

JAMA Dermatol. 2021 Aug 01;157(8):963-970
pubmed: 34232264
J Eur Acad Dermatol Venereol. 2020 Feb;34(2):406-411
pubmed: 31465592
Exp Ther Med. 2013 Aug;6(2):542-546
pubmed: 24137223
J Cosmet Dermatol. 2023 Jan;22(1):89-95
pubmed: 35403805
J Clin Aesthet Dermatol. 2021 May;14(5):26-30
pubmed: 34188746
Exp Psychol. 2019 Sep;66(5):331-345
pubmed: 31603047
Br J Dermatol. 2001 May;144(5):1038-43
pubmed: 11359394
Int J Trichology. 2019 Jul-Aug;11(4):147-152
pubmed: 31523105
J Eur Acad Dermatol Venereol. 2001 Mar;15(2):137-9
pubmed: 11495520
Eur J Dermatol. 2002 Jan-Feb;12(1):38-49
pubmed: 11809594
Int J Dermatol. 2002 Dec;41(12):867-9
pubmed: 12492971
J Invest Dermatol. 2005 Oct;125(4):659-64
pubmed: 16185263
J Eur Acad Dermatol Venereol. 2002 Sep;16(5):476-80
pubmed: 12428841
Br J Dermatol. 2009 May;160(5):1034-9
pubmed: 19183424
Soc Sci Med. 1994 Jan;38(1):159-63
pubmed: 8146707
Body Image. 2011 Sep;8(4):343-8
pubmed: 21855434
J Am Acad Dermatol. 1992 Jun;26(6):926-31
pubmed: 1607410
G Ital Dermatol Venereol. 2014 Feb;149(1):15-24
pubmed: 24566563
J Am Acad Dermatol. 1993 Oct;29(4):568-75
pubmed: 8408792

Auteurs

Erica L Aukerman (EL)

Indiana University School of Medicine, Indianapolis, Indiana, USA.

Mohammad Jafferany (M)

Department of Psychodermatology and Psychiatry, Central Michigan University, Mount Pleasant, Michigan, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH